NCT03248882

Brief Summary

Phase 2a, dose-ranging Study with PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
305

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2017

Geographic Reach
6 countries

140 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

August 22, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2019

Completed
12 months until next milestone

Results Posted

Study results publicly available

March 10, 2020

Completed
Last Updated

December 9, 2020

Status Verified

February 1, 2020

Enrollment Period

1.5 years

First QC Date

August 10, 2017

Results QC Date

February 25, 2020

Last Update Submit

December 7, 2020

Conditions

Keywords

PF-05221304NAFLDNASHfeatures of metabolic syndromeDose-Ranging Study

Outcome Measures

Primary Outcomes (1)

  • Percent Change From Baseline in Liver Fat by Magnetic Resonance Imaging-Proton Density Fat Fraction (MRI- PDFF) at Week 16

    MRI-PDFF utilized a gradient echo sequence with low flip angle (FA) to minimize T1 bias, corrected T2\* decay (due to iron overload) via modeling of the fat signal as a superposition of multiple frequency components from 5 different lipid types, and was applied in each of the 9 Couinaud segments. This technique improved fat quantification accuracy for the entire liver permitting quantification of small differences/changes following pharmacological intervention.

    Baseline (between Day -14 and Day 1), Week 16

Secondary Outcomes (5)

  • Percent Change From Baseline in Alanine Aminotransferase at Week 16

    Baseline (Day 1 pre-dose), Week 16

  • Number of Participants With Treatment-Emergent Adverse Events

    From first dose of study treatment (Day 1) up to Week 20

  • Number of Participants With Laboratory Abnormalities

    From first dose of study treatment (Day 1) up to Week 20

  • Number of Participants With Vital Signs Data Meeting Predefined Criteria

    From first dose of study treatment (Day 1) up to Week 18

  • Number of Participants With 12-Lead Electrocardiogram (ECG) Data Meeting Predefined Criteria

    From first dose of study treatment (Day 1) up to Week 18

Study Arms (5)

Placebo

PLACEBO COMPARATOR

Double-Blind, PF-05221304-matching Placebo

Drug: Placebo

PF-05221304 - 2 mg

ACTIVE COMPARATOR

PF-05221304 - 2 mg, once-daily

Drug: PF-05221304

PF-05221304 - 10 mg

ACTIVE COMPARATOR

PF-05221304 - 10 mg, once-daily

Drug: PF-05221304

PF-05221304 - 25 mg

ACTIVE COMPARATOR

PF-05221304 - 25 mg, once-daily

Drug: PF-05221304

PF-05221304 - 50 mg

ACTIVE COMPARATOR

PF-05221304 - 50 mg, once-daily

Drug: PF-05221304

Interventions

Placebo

Placebo

PF-05221304, Experimental Drug

PF-05221304 - 10 mgPF-05221304 - 2 mgPF-05221304 - 25 mgPF-05221304 - 50 mg

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body Mass Index \>= 25 kg/m2
  • Body Weight \> 50 kg
  • Liver fat (assessed via MRI-PDFF) \>= 8%
  • Biopsy-proven NASH - diagnosed in previous 24-months
  • Presumed NASH - per Sponsor's definition
  • NAFLD with minimal inflammation/fibrosis
  • Features of Metabolic Syndrome

You may not qualify if:

  • Alcohol-induced steatohepatitis or other forms of chronic liver disease
  • Positive for Hepatitis B, Hepatitis C, or Human Deficiency Virus
  • Severe Renal Impairment
  • Contraindications for MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (140)

Franco Felizarta MD

Bakersfield, California, 93301, United States

Location

eStudySite

Chula Vista, California, 91911, United States

Location

San Diego Imaging Chula Vista

Chula Vista, California, 91911, United States

Location

University of California, San Diego (Altman Clinical and Translational Research Institute)

La Jolla, California, 92037, United States

Location

University of California, San Diego

La Jolla, California, 92037, United States

Location

eStudySite

La Mesa, California, 91942, United States

Location

Clinical Trials Research

Lincoln, California, 95648, United States

Location

National Research Institute

Los Angeles, California, 90057, United States

Location

Stanford University Medical Center, Blake wilbur Building

Palo Alto, California, 04304, United States

Location

Stanford University Medical Center

Palo Alto, California, 94304, United States

Location

Huntington Medical Research Institute

Pasadena, California, 91105, United States

Location

Inland Empire Liver Foundation

Rialto, California, 92377, United States

Location

Precision Research Institute

San Diego, California, 92114, United States

Location

Quest Clinical Research

San Francisco, California, 94115, United States

Location

South Denver Gastroenterology, P.C.

Englewood, Colorado, 80113, United States

Location

Jacksonville Center for Clinical Research

Jacksonville, Florida, 32216, United States

Location

Borland-Groover Clinic

Jacksonville, Florida, 32256, United States

Location

Schiff Center for Liver Diseases/University of Miami

Miami, Florida, 33136, United States

Location

Stand Up MRI of Miami

Miami, Florida, 33145, United States

Location

Ocean Blue Medical Research Center, Inc

Miami Springs, Florida, 33166, United States

Location

Avail Clinical Research, LLC

Orange City, Florida, 32763, United States

Location

Bioclinica Research

Orlando, Florida, 32806, United States

Location

Advanced Gastroenterology Associates, LLC

Palm Harbor, Florida, 34684, United States

Location

Qps-Mra, Llc

South Miami, Florida, 33143, United States

Location

Tampa General Medical Group

Tampa, Florida, 33606, United States

Location

University of South Florida

Tampa, Florida, 33612, United States

Location

South Florida Center Of Gastroenterology, PA

Wellington, Florida, 33414, United States

Location

Independent Imaging

Wellington, Florida, 33449, United States

Location

East-West Medical Research Institute

Honolulu, Hawaii, 96814, United States

Location

Invision Imaging

Honolulu, Hawaii, 96814, United States

Location

Midwest Institute for Clinical Research

Indianapolis, Indiana, 46260, United States

Location

Heartland Research Associates, LLC

Wichita, Kansas, 67207, United States

Location

Ascension Via Christi Imaging at St. Francis

Wichita, Kansas, 67214, United States

Location

Tulane University Health Sciences Center

New Orleans, Louisiana, 70112, United States

Location

Ochsner Medical Center

New Orleans, Louisiana, 70121, United States

Location

Mercy Medical Center

Baltimore, Maryland, 21202, United States

Location

Digestive Disease Associates, PA

Catonsville, Maryland, 21228, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Henry Ford Health System

Detroit, Michigan, 48202, United States

Location

Mayo Clinic- Main Campus

Rochester, Minnesota, 55905, United States

Location

Gastrointestinal Associates, PA

Flowood, Mississippi, 39232, United States

Location

Colonnades at Baptist

Jackson, Mississippi, 39202, United States

Location

BioTelemetry Research

Rochester, New York, 14623, United States

Location

Investigational Drug Service, University of North Carolina Hospitals

Chapel Hill, North Carolina, 27514, United States

Location

The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC)

Chapel Hill, North Carolina, 27599, United States

Location

The University of North Carolina at Chapel Hill, Biomedical Research Imaging Center (MRI Facility)

Chapel Hill, North Carolina, 27599, United States

Location

Wake Research Associates, LLC

Raleigh, North Carolina, 27612, United States

Location

PMG Research of Wilmington, LLC

Wilmington, North Carolina, 28401, United States

Location

PMG Research, Inc.

Winston-Salem, North Carolina, 27103, United States

Location

Sterling Research Group, Ltd.

Cincinnati, Ohio, 45219, United States

Location

Prime Imaging (Chattanooga Outpatient Center)

Chattanooga, Tennessee, 37404, United States

Location

ClinSearch

Chattanooga, Tennessee, 37421, United States

Location

Touchstone

Austin, Texas, 78705, United States

Location

Baylor College of Medicine - Advanced Liver Therapies

Houston, Texas, 77030, United States

Location

Pinnacle Clinical Research

Rollingwood, Texas, 78746, United States

Location

Clinical Trials of Texas, Inc.

San Antonio, Texas, 78229, United States

Location

Pinnacle Clinical Research, PLLC

San Antonio, Texas, 78229, United States

Location

Clinical Research Advantage, Inc./Wasatch Peak Family Practice

Layton, Utah, 84041, United States

Location

National Clinical Research - Richmond, Inc.

Richmond, Virginia, 23294, United States

Location

Harborview Medical Center

Seattle, Washington, 98104, United States

Location

Australian Clinical Research Network

Maroubra, New South Wales, 2035, Australia

Location

Spectrum Medical Imaging

Randwick, New South Wales, 2013, Australia

Location

Castlereagh Imaging

Westmead, New South Wales, 2145, Australia

Location

Storr Liver Centre, Westmead Hospital

Westmead, New South Wales, 2145, Australia

Location

Dr. Jones & Partners Medical Imaging

Adelaide, South Australia, 5000, Australia

Location

Royal Adelaide Hospital, Department of Gastroenterology and Hepatology

Adelaide, South Australia, 5000, Australia

Location

Flinders Medical Centre/Department of Gastroenterology & Hepatology

Adelaide, South Australia, 5042, Australia

Location

Radiology SA

Adelaide, South Australia, 5067, Australia

Location

Royal Melbourne Hospital

Parkville, Victoria, 3050, Australia

Location

Dr TG Elliott Inc - BC Diabetes

Vancouver, British Columbia, V5Y 3W2, Canada

Location

False Creek Healthcare Centre

Vancouver, British Columbia, V5Z 1C6, Canada

Location

False Creek Healthcare

Vancouver, British Columbia, V5Z 1C6, Canada

Location

LAIR Centre

Vancouver, British Columbia, V5Z 1H2, Canada

Location

Discovery Clinical Services Ltd.

Victoria, British Columbia, V8T 5G4, Canada

Location

West Coast Medical Imaging

Victoria, British Columbia, V8Z 0B9, Canada

Location

Nova Scotia Health Authority, QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 1V7, Canada

Location

Nova Scotia Health Authority, QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 2Y9, Canada

Location

Nova Scotia Health Authority - QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 3A7, Canada

Location

Aggarwal and Associates Limited

Brampton, Ontario, L6T 0G1, Canada

Location

St. Joseph's Health Care London

London, Ontario, N6A 4V2, Canada

Location

London Health Sciences Centre - University Hospital

London, Ontario, N6A 5A5, Canada

Location

Oxford Medical Imaging

Mississauga, Ontario, L5R 3K7, Canada

Location

LMC Clinical Research Inc. (Bayview)

Toronto, Ontario, M4G 3E8, Canada

Location

St. Michael's Hospital - MRI Research Centre

Toronto, Ontario, M5B 1W8, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

University Health Network (UHN) - Toronto General Hospital - Toronto Centre for Liver Disease (TCLD)

Toronto, Ontario, M5G 2C4, Canada

Location

University of Toronto - Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

University Health Network (UHN)

Toronto, Ontario, M5G 2M9, Canada

Location

Toronto Liver Centre - Liver Care Centre Corporation

Toronto, Ontario, M6H 3M1, Canada

Location

Resonance Magnetique du Saguenay-Lac-Saint-Jean

Chicoutimi, Quebec, G7H 4J1, Canada

Location

Ecogene-21

Chicoutimi, Quebec, G7H 7K9, Canada

Location

Medpharmgene Inc

Montreal, Quebec, H2K 1H2, Canada

Location

Clinique de Medecine Urbaine du Quartier Latin

Montreal, Quebec, H2L 4E9, Canada

Location

Centre de recherche du CHUM

Montreal, Quebec, H2X 0A9, Canada

Location

Cedar Cancer Center - McGill University Health Centre

Montreal, Quebec, H4A 3J1, Canada

Location

Chronic Viral Illness Service - Royal Victoria Hospital - McGill University Health Centre (MUHC)

Montreal, Quebec, H4A 3J1, Canada

Location

McGill University Health Centre

Montreal, Quebec, H4A 3J1, Canada

Location

Research Institute of the MUHC

Montreal, Quebec, H4A 3J1, Canada

Location

Radiologie Varad

Montreal, Quebec, H5B 1B2, Canada

Location

IRM Quebec

Québec, Quebec, G1J0H4, Canada

Location

IRM Quebec

Québec, Quebec, G1J5B9, Canada

Location

CHU de Quebec - Universite Laval - site Centre Hospitalier de l'Universite Laval (CHUL)

Québec, Quebec, G1V 4G2, Canada

Location

Centre de recherche de l'Institut Universitaire de Cardiologie et de pneumologie de Quebec

Québec, Quebec, G1V 4G5, Canada

Location

Centre de recherche Saint-Louis

Québec, Quebec, G1W 4R4, Canada

Location

IRM Québec - Clinique St-Louis

Québec, Quebec, G1W 4R4, Canada

Location

Alpha Recherche Clinique

Québec, Quebec, G3K 2P8, Canada

Location

Clinix

Québec, Quebec, G3K 2P8, Canada

Location

Recherche Medicale St-Jerome Inc

Saint-Jérôme, Quebec, J7Z 5T3, Canada

Location

Centre Intégré Universitaire de Santé et de Services Sociaux (CIUSSS) de l'Estrie

Sherbrooke, Quebec, J1G 2E8, Canada

Location

Hillel Yaffe Medical Center

Hadera, 3810101, Israel

Location

Rambam Health Care Campus

Haifa, 3109601, Israel

Location

Lady Davis Carmel Medical Center

Haifa, 3434104, Israel

Location

Shaare Zedek Medical Center

Jerusalem, 9103102, Israel

Location

Hadassah Hebrew University Medical Center - Ein Kerem

Jerusalem, 9112001, Israel

Location

Galilee Medical Center

Nahariya, 2210001, Israel

Location

Holy Family Hospital

Nazareth, 1610001, Israel

Location

Rabin Medical Center

Petah Tikva, 4941492, Israel

Location

The Chaim Sheba Medical Center

Ramat Gan, 5265601, Israel

Location

Tel-Aviv Sourasky Medical Center

Tel Aviv, 6423906, Israel

Location

ClinicMed Badurski i wspolnicy Spolka Jawna

Bialystok, 15-879, Poland

Location

Synexus Polska Sp. z o.o. Oddzial w Gdansku

Gdansk, 80-382, Poland

Location

Centrum Badan Klinicznych PI-House Sp. z o.o.

Gdansk, 80-546, Poland

Location

Synexus Polska Sp. z o.o. Oddzial w Gdyni

Gdynia, 81-537, Poland

Location

Osrodek Badan Klinicznych

Jaworze, 43-384, Poland

Location

Synexus Polska Sp. z o.o. Oddzial w Katowicach

Katowice, 40-040, Poland

Location

Silmedic Sp. z o.o. Oddzial w Katowicach

Katowice, 40-282, Poland

Location

Centrum Medyczne A-Z Clinic

Krakow, 31-315, Poland

Location

Krakowskie Centrum Medyczne sp. z o.o.

Krakow, 31-501, Poland

Location

Gabinet Lekarski Malgorzata Saryusz-Wolska

Lodz, 90-132, Poland

Location

Synexus Polska Sp. z o.o Oddzial w Poznaniu

Poznan, 60-702, Poland

Location

Centrum Medyczne Medyk

Rzeszów, 35-326, Poland

Location

Synexus Polska Sp. z o. o. Oddzial w Warszawie

Warsaw, 01-192, Poland

Location

Niepubliczny Zaklad Opieki Zdrowotnej Centrum Badan Klinicznych

Wroclaw, 50-349, Poland

Location

Synexus Polska Sp. z o.o. Oddzial we Wroclawiu

Wroclaw, 50-381, Poland

Location

DOBROSTAN - Gabinety Lekarskie

Wroclaw, 53-301, Poland

Location

Changhua Christian Hospital

Changhua, Changhua County, 500, Taiwan

Location

Chung-Ho Memorial Hospital, Kaohsiung Medical University

Kaohsiung City, 807, Taiwan

Location

National Cheng-Kung University Hospital

Tainan, 704, Taiwan

Location

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Taipei Veterans General Hospital

Taipei, 11217, Taiwan

Location

Related Publications (2)

  • Sivakumar P, Saul M, Robinson D, King LE, Amin NB. SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH). Sci Rep. 2024 Jul 24;14(1):17072. doi: 10.1038/s41598-024-67843-8.

  • Calle RA, Amin NB, Carvajal-Gonzalez S, Ross TT, Bergman A, Aggarwal S, Crowley C, Rinaldi A, Mancuso J, Aggarwal N, Somayaji V, Inglot M, Tuthill TA, Kou K, Boucher M, Tesz G, Dullea R, Bence KK, Kim AM, Pfefferkorn JA, Esler WP. ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat Med. 2021 Oct;27(10):1836-1848. doi: 10.1038/s41591-021-01489-1. Epub 2021 Oct 11.

Related Links

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Results Point of Contact

Title
Pfizer ClinicalTrials.gov Call Center
Organization
Pfizer, Inc

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-Blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: C1171002 is a randomized, double blind, placebo controlled, 5 arm (placebo, plus 4 active doses of PF 05221304), parallel group study.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2017

First Posted

August 14, 2017

Study Start

August 22, 2017

Primary Completion

February 26, 2019

Study Completion

March 27, 2019

Last Updated

December 9, 2020

Results First Posted

March 10, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will share

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.

More information

Locations